Evidence map›Paper›PMID 41940087›Full record

ArticleFrontiers in cardiovascular medicine2026

Case Report: Primary vascular sarcoma presenting as massive pulmonary embolism salvaged by veno-arterial extracorporeal membrane oxygenation and interventional therapy.

Jinmei Huang, Peiyi Lin, Liting Wang, Pingping Xiao, Wei Fan, Lihong Tian, Yi Zhang, Shufan Wu, Zhigao Dong

Abstract readCase Reports
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jinmei HuangDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China.
Peiyi LinDepartment of Interventional Vascular Surgery, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China.
Liting WangDepartment of Pathology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China.
Pingping XiaoDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China.
Wei FanDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China.
Lihong TianDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China.
Yi ZhangDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China.
Shufan WuDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China.
Zhigao DongDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Acute massive pulmonary embolism (massive PE) caused by primary vascular-derived sarcoma is extremely rare in clinical practice. Massive PE results in severe shock or cardiac arrest, with high mortality and adverse clinical progression. We report the case of a young woman with a primary vascular-derived sarcoma-related massive PE, diagnosed through aspiration biopsy performed during angiography. The patient was successfully treated using veno-arterial extracorporeal membrane oxygenation (VA-ECMO) combined with interventional thrombectomy, thrombolysis, and anticoagulation. Case description: A 34-year-old woman experienced 2 days of right thigh pain and acute dyspnea, culminating in transient syncope (3 h). On admission, she was hemodynamically unstable, with markedly elevated D-dimer levels. Computed tomography angiography confirmed a massive PE and extensive deep vein thrombosis involving the right iliac and femoral veins. Within the first hour after admission, she experienced cardiorespiratory arrest, requiring immediate initiation of VA-ECMO. Combined therapy (interventional thrombectomy, thrombolysis, and anticoagulation) stabilized cardiopulmonary function, allowing successful weaning from VA-ECMO. Venography revealed a filling defect from the right common iliac vein into the inferior vena cava. Pathological examination of an aspirated thrombus specimen revealed the presence of atypical cells. Immunohistochemistry supported the diagnosis of primary vascular-derived sarcoma (angiosarcoma). Following clinical stabilization, she was discharged on therapeutic rivaroxaban and scheduled for systemic chemotherapy for angiosarcoma. Conclusions: This case illustrates that VA-ECMO, combined with interventional thrombectomy, thrombolysis, and anticoagulation, is an effective salvage therapy for angiosarcoma-associated massive PE, particularly in patients with hemodynamic instability. It highlights the need to suspect occult malignancy, including vascular sarcomas, in young patients with unprovoked massive PE. Moreover, aspiration biopsy during angiography, when clinically indicated, can serve as a critical diagnostic tool.

Indexed as

acute massive pulmonary embolismcase reportECMOinterventional thrombectomyprimary vascular-derived sarcomathrombolytic

Identifiers

PMID41940087
PMCPMC13044003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.